SCHEMBL7182953

SCHEMBL7182953

Cc1ccc(OC(C)C)c(C=CC(=O)c2ccc(C(=O)N(C)C)cc2)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 3/20 0.45
CAPN1 P07384 1/20 0.44
MAPT P10636 4/20 0.43
LMNA P02545 3/20 0.43
ALDH1A1 P00352 1/20 0.43
PDE4A P27815 1/20 0.42
PDE4B Q07343 1/20 0.42
PDE4C Q08493 1/20 0.42
PDE4D Q08499 1/20 0.42
CYP1A1 P04798 1/20 0.42
CYP1B1 Q16678 1/20 0.42
PTPN1 P18031 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.41
KDM4E B2RXH2 1/20 0.41
ATM Q13315 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
AR P10275 1/20 0.40
MEN1 O00255 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7177356 0.87 ABCG2 (0.44) ABCG2CAPN1MAPTLMNAPDE4A
SCHEMBL7190651 0.86 ABCG2 (0.61) ABCG2CAPN1MAPTLMNAALDH1A1
SCHEMBL7178873 0.86 ABCG2 (0.48) ABCG2CAPN1MAPTLMNAPDE4A
SCHEMBL7178869 0.86 ABCG2 (0.48) ABCG2CAPN1MAPTLMNAPDE4A
SCHEMBL7185759 0.85 ABCG2 (0.43) ABCG2CAPN1MAPTLMNAALDH1A1
SCHEMBL7178602 0.85 PTPN1 (0.44) ABCG2CAPN1MAPTLMNAPDE4A
SCHEMBL9204172 0.84 MAPT (0.53) CAPN1MAPTLMNAALDH1A1CYP1A1
SCHEMBL9204167 0.84 MAPT (0.53) CAPN1MAPTLMNAALDH1A1CYP1A1
SCHEMBL7192282 0.83 LMNA (0.58) ABCG2CAPN1MAPTLMNAALDH1A1
SCHEMBL9199131 0.83 ABCG2 (0.45) ABCG2CAPN1MAPTLMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6603046-B1 The invention is drawn to novel bis-aromatic a, beta -unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria. LICA PHARMACEUTICALS A/S (DK) 2003-08-05 US disclosed
EP-0634927-B1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA LICA PHARMACEUTICALS AS (DK) 2001-07-04 EP disclosed
US-5985935-A PARASITICIDES OR BACTERICIDES STATENS SERUMINSTITUT (DK) 1999-11-16 US disclosed
EP-0634927-A1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA STATENS SERUMINSTITUT (DK) 1995-01-25 EP disclosed
WO-1993017671-A1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA STATENS SERUMINSTITUT (DK) 1993-09-16 WO disclosed